Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (33 ops.)
Latest filing published 27 May 2026 for Kymera Therapeutics, Inc., €309k.
Filing timeline
BuySaleJeremy G. Chadwick
Insider track record
Disclosed buys
0
Disclosed sells
33
Signal history
Jeremy G. Chadwick: trading record in brief
This profile gathers the share dealings of Jeremy G. Chadwick in Kymera Therapeutics, Inc. The record holds 47 filings, for trades running from 22 May 2023 to 27 May 2026.
The open-market record consists of 33 sales worth €13.6M, with no purchase. Besides market trades, the filings include 4 share grants and 10 option exercises. Since January 2026: no purchases and 29 sales on the market.
Most recently, on 27 May 2026, the filings show an open-market sale worth €309k in Kymera Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jeremy G. Chadwick
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations28 total
4,500 shares@ US$80.02460.0036% mcap11.0% of flowCommon StockSEC:0001193125-26-242266:3
551 shares@ US$80.70820.0004% mcap1.4% of flowCommon StockSEC:0001193125-26-242266:4
3,730 shares@ US$78.35690.0029% mcap9.0% of flowCommon StockSEC:0001193125-26-242266:0
324 shares@ US$79.170.0003% mcap0.8% of flowCommon StockSEC:0001193125-26-242266:1
3,800 shares@ US$79.39230.0030% mcap9.2% of flowCommon StockSEC:0001193125-26-242266:2
3,679 shares@ US$81.5030.0030% mcap9.2% of flowCommon StockSEC:0001193125-26-242266:5
600 shares@ US$82.07670.0005% mcap1.5% of flowCommon StockSEC:0001193125-26-242266:6
100 shares@ US$30.170.0000% mcap0.1% of flowCommon StockSEC:0001193125-26-177400:0
200 shares@ US$43.500.0001% mcap0.3% of flowCommon StockSEC:0001193125-26-177400:1
300 shares@ US$90.000.0003% mcap0.8% of flowCommon StockSEC:0001193125-26-177400:2
4,466 shares@ US$30.170.0013% mcap4.1% of flowCommon StockSEC:0001193125-26-159538:0
785 shares@ US$43.500.0003% mcap1.0% of flowCommon StockSEC:0001193125-26-159538:1
5,251 shares@ US$90.00160.0047% mcap14.3% of flowCommon StockSEC:0001193125-26-159538:2
1,300 shares@ US$43.500.0006% mcap1.7% of flowCommon StockSEC:0001193125-26-159538:3
1,300 shares@ US$90.000.0012% mcap3.5% of flowCommon StockSEC:0001193125-26-159538:4
7,600 shares@ US$85.379212.8% of flowCommon StockSEC:0001193125-26-138371:1
13,540 shares@ US$85.414422.8% of flowCommon StockSEC:0001193125-26-138371:3
7,600 shares@ US$29.644.5% of flowCommon StockSEC:0001193125-26-138371:0
14,640 shares@ US$29.648.6% of flowCommon StockSEC:0001193125-26-138371:2
1,100 shares@ US$86.051.9% of flowCommon StockSEC:0001193125-26-138371:4
84,400 shares@ US$29.6449.5% of flowCommon StockSEC:0001193125-26-124367:0
20,000 shares@ US$43.5026.7% of flowCommon StockSEC:0001193125-26-102630:0
12,575 shares0Common StockSEC:0001193125-26-091985:0
2,575 shares@ US$29.29542.4% of flowCommon StockSEC:0000950170-25-076993:0
25,000 shares0Common StockSEC:0000950170-25-031147:0
25 of 28 declarations
